John M. Leonard

Companies

• Intellia TherapeuticsPresident May 15, 2018 to now¹
• Intellia TherapeuticsChief executive officer Jan 29, 2018 to now²
• Intellia TherapeuticsBoard member May 5, 2016 to now³
• IQVIA Holdings, Inc.Board member Feb 13, 2015 to now⁴
• Intellia TherapeuticsChief Medical Officer May 5, 2016 to Dec 14, 2017³
• Chimerix (United States)Board member Jun 24, 2014 to Jun 29, 2017⁵
• AbbVieSVP, Chief Scientific Officer Dec 7, 2012 to Mar 19, 2013⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Intellia Therapeutics NTLA1,205,479 shares⁷$13.8M at $11.48Aug 24, 2026
• IQVIA Holdings, Inc. IQV16,946 shares⁸$4.5M at $266.91Apr 23, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 21, 2026Sold 2,785 shares at $13.00 of Intellia Therapeutics⁷
• Aug 20, 2026Sold 19,890 shares at $12.60 of Intellia Therapeutics⁷
• Apr 23, 2026Granted 1,571 shares of IQVIA Holdings, Inc.⁸
• Mar 1, 2026Granted 156,400 shares of Intellia Therapeutics⁹
• Jan 5, 2026Sold 34,146 shares at $9.21 of Intellia Therapeutics¹⁰
• Dec 12, 2025Exercised options 8,557 shares at $6.83 of Intellia Therapeutics¹¹
• Dec 11, 2025Sold 5,355 shares at $9.59 of Intellia Therapeutics¹¹
• Dec 11, 2025Sold 32,832 shares at $9.47 of Intellia Therapeutics¹¹
• Dec 11, 2025Sold 49,959 shares at $9.49 of Intellia Therapeutics¹¹
• Dec 11, 2025Exercised options 49,959 shares at $6.83 of Intellia Therapeutics¹¹
• Apr 24, 2025Granted 1,592 shares of IQVIA Holdings, Inc.¹²
• Mar 1, 2025Granted 136,000 shares of Intellia Therapeutics¹³
• Jan 3, 2025Sold 26,807 shares at $12.18 of Intellia Therapeutics¹⁴
• Jan 1, 2025Exercised options 7,850 shares of Intellia Therapeutics¹⁵
• May 7, 2024Granted 1,047 shares of IQVIA Holdings, Inc.¹⁶
• Mar 1, 2024Granted 113,586 shares of Intellia Therapeutics¹⁷
• Jan 3, 2024Sold 19,223 shares at $29.46 of Intellia Therapeutics¹⁸
• Jan 1, 2024Exercised options 7,848 shares of Intellia Therapeutics¹⁹
• May 10, 2023Granted 1,063 shares of IQVIA Holdings, Inc.²⁰
• Mar 1, 2023Granted 91,036 shares of Intellia Therapeutics²¹
• Jan 4, 2023Sold 6,673 shares at $37.21 of Intellia Therapeutics²²
• Jan 1, 2023Exercised options 7,848 shares of Intellia Therapeutics²³
• May 11, 2022Granted 995 shares of IQVIA Holdings, Inc.²⁴
• Mar 1, 2022Granted 40,990 shares of Intellia Therapeutics²⁵
• Jan 1, 2022Sold 2,493 shares at $112.26 of Intellia Therapeutics²⁵